發送短信 : Cost-utility and budget impact analyses of gefitinib in second-line treatment for advanced non-small cell lung cancer from Thai payer perspective

             ___       _____    ______    ______  
  ____      / _ \\    / ___//  /_   _//  /_____// 
 |    \\   / //\ \\   \___ \\   -| ||-   `____ `  
 | [] ||  |  ___  ||  /    //   _| ||_   /___//   
 |  __//  |_||  |_|| /____//   /_____//  `__ `    
 |_|`-`   `-`   `-` `-----`    `-----`   /_//     
 `-`                                     `-`